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The immune system functions in the organ/tissue of the body.
The immune cell differentiation and function are influenced
by the organ/tissue microenvironments in which they reside,
and the interaction of immune cells with the organ/tissue
microenvironments may affect and even determine the
outcome of the immune responses (Hu and Pasare, 2013;
Zajac and Harrington, 2014). It has been increasingly
appreciated that the immunologic characterization from
professional immune organs including thymus, bone mar-
row, spleen, and lymph node, is greatly distinguished from
that in mucosal immune organs including skin, intestine,
lung, pancreas, uterus and kidney, and other organs such
as liver, bone, brain, maternal-fetal interface, and so on.
Each organ/tissue is characterized with its own anatomy
and microenvironment, in which immune cell populations
and subsets may have unique functional molecules, forming
“unique regional immune features”. The regional immune
responses play an important role in tissue homeostasis and
are extensively involved in the pathogenesis of the major
diseases related to each tissue/organ.
With the research progressed, a more clear description of
the regional immune features has been presented, such as
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novel tissue-resident immune cell subsets, organ-special-
ized immune recognition, organ-specific factors instructing
regional immune responses in liver, lung, intestine, bone,
brain, uterus, adipose, kidney, tumor, etc. For example,
specialized tissue-resident macrophages, including Kupffer
cells in the liver, alveolar macrophages in the lung, microglia
in the brain, osteoclasts in the bone, and histiocytes in the
intestinal connective tissue, exhibit distinct functions due to
their resident tissue (Murray and Wynn, 2011). Specialized
tissue-resident regulatory T cells in the visceral adipose tis-
sue (VAT Tregs), muscle Tregs, bone Tregs and skin memory
Tregs, have also been reported with their unique functions
in local tissues (Zhou et al., 2015). Innate immune cells
continuously receive signals from the resident environment,
such as commensal microbiota signals in mucosal organs,
which will influence the outcome of immune responses. In
this issue, Zhang et al. reviewed the innate recognition of
microbial-derived signals in immunity and inflammation
(Zhang and Liang, 2016), which will help us understand the
local immune responses.
Liver is an unique organ with predominant innate immu-
nity, enriched with Kupffer cells, NK cells, NKT cells and
γδ T cells (Gao et al., 2008). Current studies have revealed
that NK cells are not a homogeneous population, but instead
consist of distinct subsets including conventional NK (cNK)
cells and tissue-resident NK (trNK) cells. In this issue, Peng
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and Tian summarized the phenotypic and functional features
of liver trNK cells (Peng and Tian, 2016). In mice, liver NK
cells can be divided into two distinct subsets: CD49a−DX5+
cNK and CD49a+DX5− trNK cells which reside in the liver
sinusoid blood and confer memory-like responses in contact
hypersensitivity (CHS) models (Peng et al., 2013). Liver
trNK cells and cNK cells require different transcription
factors for their development, thus representing sepa-
rate developmental lineages (Constantinides et al., 2014;
Daussy et al., 2014; Klose et al., 2014; Mackay et al., 2016).
They also overviewed recent advances in human liver trNK
cells and discussed the striking shared hallmarks of trNK
cells in different tissues. Human hepatic CD56bright NK cells
express trNK cell markers such as CD69 and CXCR6, and
exhibit unique transcriptiona profiles compared to cNK cells
(Hudspeth et al., 2016). Similar to murine liver trNK cells, a
proportion of human hepatic CD56bright NK cells with the ex-
pression of CD49a are T-bet+Eomes− (Marquardt et al., 2015).
Additionally, in this issue Han et al. identified a new subset
of inflammation-induced CD69+ Kupffer cells during Liste-
ria monocytogenes infection (Zhang et al., 2016). Hepatic
CD69+ Kupffer cells expressed higher levels of CD11b, but
produced lower levels of F4/80, which could not be depleted
by clodronate liposome administration. Hepatic CD69+
Kupffer cells suppressed Ag-nonspecific and OVA-specific
CD4+ T cell proliferation through membrane-bound TGF-β1
(mTGF-β1). CD69+ Kupffer cells may contribute to pro-
tect host from pathological injure by preventing immune
over-activation.
During human pregnancy, an orchestrated evolutionaryma-
ternal adaption toward tolerance of the semiallogeneic fetus
is required. In the decidua, remodeling of the immune system
involves NK cells, macrophages, T cells and DCs to alter the
local microenvironment (Fu et al., 2014; Lima et al., 2014).
NK cells as the largest population of immune cells during the
first trimester in human decidua, accounting for 50%–70%
of the total number of immune cells after 9–12 weeks of
pregnancy, showed a close reaction to invasive fetal tro-
phoblasts and stromal cells (Colucci and Kieckbusch, 2015;
Tao et al., 2015). Evidence shows decidual NK cells act as
sentinel cells to control local inflammation and tolerance,
and mediate the regulation of fetal growth. In this issue, Fu et
al. summarized the concepts and rationale for the remodeled
immune system during pregnancy, and the formation and
education of decidual NK cells (Fu and Wei, 2016). Most
decidual NK cells are CD56brightCD16− NK cells, which
express CXCR4, and can be selectively recruited into the
decidua by interaction with chemokine CXCL12 secreted by
DSCs and EVTs (Hanna et al., 2003; Wu et al., 2005).
Adipose tissues, including white, brown and beige
fat, play pivotal roles in metabolic homeostasis
(Rosen and Spiegelman, 2014). Macrophages, mast
cells, neutrophils, eosinophils, ILC2, T cells and
B cells have all been found in adipose tissue and
were involved in obesity-related metabolic dysfunc-
tions (Cipolletta et al., 2012; Feuerer et al., 2009;
Liu et al., 2009; Lynch et al., 2012; Molofsky et al., 2013;
Talukdar et al., 2012; Winer et al., 2009; Winer et al., 2011;
Wu et al., 2011). Particularly, macrophages as the critical
effector cells in orchestrating inflammation have been most
extensively investigated to explore their roles in obesity-as-
sociated metabolic inflammation and insulin resistance
(McNelis and Olefsky, 2014). In this issue, Qiu et al.
reviewed the metabolic activation and functional properties
of adipose tissue macrophage (ATM) including M1 and
M2 macrophages (Qiu et al., 2016), which would help us
better understand the pathogenic and/or protective roles
of ATM and the translational opportunities for developing
novel therapeutics against obesity, type 2 diabetes and other
related metabolic diseases.
Osteoimmunology was firstly introduced in 2000, in-
dicating the bone and immune system have an intense
interaction and should be considered as a functional unit
(Arron and Choi, 2000). Osteoblasts (OBs) contribute to
hematopoietic progenitor growth and HSC pool maintenance
through Notch signal and osteopontin (OPN) production
(Calvi et al., 2003; Nilsson et al., 2005). The development
and response of immune cells associate to bone remodeling;
on the other hand, activated immune cells are involved in
bone metabolism regulation, and mediate osteoporosis and
bone erosion under pathological conditions such as rheuma-
toid arthritis (RA), spondyloarthropathy (SPA), osteoporosis
(OP), and periodontal disease (PD). In this issue, Zhao et
al. presented current understanding of osteoimmunology
and emphasized on the RANK/RANKL/OPG signaling in
bone remodeling and immune responses (Zhao et al., 2016).
Recent research progress in the interactions between T cells,
B cells, DCs and bone cells, in the role of several kinds
of cytokines including M-CSF, TNF-α, IL-1, IFN-γ, IL-4,
IL-10, IL-6, TGF-β, OPN and complement system in bone
homeostasis were also summarized in this review, particu-
larly their pathogenesis in major diseases.
The central nervous system (CNS) as an immune privi-
leged organ, owns its local tissue barrier and immunosup-
pressive microenvironment. Interestingly, Glial cells includ-
ing activated microglia and astrocytes, participate in local
immune regulation within the CNS. Further, a specialized
CNS-cytokine network was constituted and regulated the de-
velopment and recovery from autoimmune diseases within
the CNS (Xiao and Link, 1998). Additionally, numerous
myeloid cell subsets were found in CNS-adjoining tissues,
namely the meninges, the perivascular space, and the choroid
plexus (Brendecke and Prinz, 2015). These immune cells
have been demonstrated to be involved in the initiation, pro-
gression and resolution of multiple sclerosis (MS). In this is-
sue, Yan et al. reported a unique group of patients with neu-
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romyelitis optica spectrum disorder (NMOSD) who carried
autoantibodies of aquaporin-4 (AQP4) and myelin-oligoden-
drocyte glycoprotein (MOG) (Yan et al., 2016). They found
NMOSD patients carrying both anti-AQP4 and anti-MOG
antibodies exhibited combined features of prototypic NMO
and relapsing-remitting form of MS, whereas NMOSD with
only anti- MOG antibody exhibited an “intermediate” phe-
notype between NMOSD and MS, indicating that anti-MOG
antibody might be pathogenic in NMOSD patients and that
determination of anti-MOG antibody may be instructive for
management of NMOSD patients.
The kidney has its unique organizational structure and
physiological functions. It has been known recruitment of
leukocytes into the kidney occurs in capillaries of the renal
glomeruli and in postcapillary venules of the renal cor-
tex, which is tissue-specific (Rossaint and Zarbock, 2013).
Kidney diseases are protean, such as acute kidney injury
(AKI), autoimmune glomerulonephritis, and rejection of
kidney transplants. Strong evidence demonstrates immune
cells, predominantly DCs and macrophages determine both
renal tissue injury and subsequent reparative responses
(Rogers et al., 2014). However, direct kidney injurymediated
by renal infiltrated T cells has not been clearly elucidated
in humans. In this issue, Hu et al. detected different types
of T cells and macrophages in the renal biopsy tissues from
patients of anti-glomerular basement membrane (GBM) dis-
ease (Hu et al., 2016). They found that the distribution of T
cells was predominant in the peri-glomerular and interstitial
areas, particularly, the infiltrating CD8+ T cells correlated
with the percentage of ruptured Bowman’s capsules, which
may participate in the pathogenic mechanism of glomerular
damage.
Tumor tissue is also a kind of important regional immune
response area. Tumor associated immune cells undergo phe-
notypic and functional alterations due to the tumor microen-
vironments (Liu and Cao, 2015a; Liu and Cao, 2015b). In
this issue, Xie et al. reported lactic acid in tumor microen-
vironments inhibited the production of IFN-γ and IL-4 in
NKT cells, and these dysfunctions of NKT cells could sim-
ply be induced by low extracellular pH through inhibiting
mTOR signaling (Xie et al., 2016). It is interesting that tu-
mor acidicmicroenvironments could regulate immune cell re-
sponse through modulating cellular metabolisms. Addition-
ally, in the tumor microenvironment a variety of immune fac-
tors will alter and aggravate the disease process. Also, Lu
et al. reported IL-17 could inhibit the formation of malig-
nant pleural effusion (MPE) via promoting the differentia-
tion of Th9 and Th2 cells in the tumor microenvironments
(Lu et al., 2016).
Based on the characteristics of regional immune responses,
the future research will focus on discovering novel immune
cell subsets and their origin and development in certain types
of tissue/organs, exploring the key functional molecules of
the tissue-resident immune cell subsets and their interac-
tions with tissue/organ microenvironments, clarifying their
immunological mechanisms in organ-related major diseases,
explaining the local environmental factors involved in the
tissue residency, which will provide a theoretical basis for the
prevention and control of these major diseases and reveal the
possible immune intervention targets and immune treatment.
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